Angeborene Thrombozytenfunktionsstörungen

Kirstin Sandrock-Lang; Rüdiger Wentzell; Sentot Santoso; Barbara Zieger

doi:10.5482/HAMO-14-11-0067

Hämostaseologie, Table of Contents

Hamostaseologie 2016; 36(03): 178-186
DOI: 10.5482/HAMO-14-11-0067

Review

Schattauer GmbH

Angeborene Thrombozytenfunktionsstörungen

Inherited platelet disorders

Kirstin Sandrock-Lang

¹Department of Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Germany

,

Rüdiger Wentzell

²Department of Pediatrics, Lukaskrankenhaus, Neuss, Germany

,

Sentot Santoso

³Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University of Giessen, Germany

,

Barbara Zieger

¹Department of Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Germany

› Author Affiliations

Abstract

Zusammenfassung

Angeborene Thrombozytopathien können zu Blutungssymptomen unterschiedlichen Schweregrades führen, da die Thrombozyten nicht mehr ihre Funktion nach einer Gefäß-verletzung erfüllen können. In manchen Fällen sind Thrombozytopathien schwierig zu diagnostizieren und können Probleme in der Therapie und im Management verursachen. Dieser Review beschreibt den klinischen und molekulargenetischen Phänotyp der verschiedenen angeborenen Thrombozytopathien. Die angeborenen Thrombozytopathien werden entsprechend des Thrombozytendefekts eingeteilt: Rezeptordefekte (Adhäsion oder Aggregation), Sekretionsdefekte und Zytoskelettdefekte.

Die am besten charakterisierten thrombozytären Rezeptordefekte sind die Glanzmann Thrombasthenie (Defekt des Integrins [uni03B1]IIb[uni03B2]3) und das Bernard-Soulier Syndrom (Defekt des GPIb/IX/V Rezeptors). Umfassende Fall-berichte über die Blutungsdiathese sowie die Untersuchung der Thrombozytenaggregation bzw. -agglutination und Rezeptorexpression von Patienten, die an der Glanzmann Thrombasthenie (GT) oder am Bernard-Soulier Syndrom (BSS) leiden, sollen diesen Review ergänzen. Darüber hinaus wird das HermanskyPudlak Syndrom (HPS) als eine bedeutende Störung der [uni03B4]-Granula Sekretion zusammen mit einer Fallbeschreibung eines Patienten, der an HPS Typ 1 leidet, beschrieben.

Summary

Inherited platelet disorders may be the cause of bleeding symptoms of varying severity as platelets fail to fulfil their haemostatic role after vessel injury. Platelet disorders may be difficult to diagnose (and are likely to be mis-diagnosed) and raise problems in therapy and management. This review explores the clinical and molecular genetic phenotype of several inherited disorders. Inherited platelet disorders can be classified according to their platelet defects: receptor defects (adhesion or aggregation), secretion disorder, and cytoskeleton defects.

The best characterized platelet receptor defects are Glanzmann thrombasthenia (inte-grin [uni03B1]IIb[uni03B2]3 defect) and Bernard-Soulier syndrome (defect of GPIb/IX/V). Detailed case reports of patients suffering from Glanzmann thrombasthenia (GT) or Bernard-Soulier syndrome (BSS) showing the bleeding diathesis as well as investigation of platelet aggregation/agglutination and platelet receptor expression will complement this review. In addition, Hermansky-Pudlak syndrome (HPS) as an important defect of [uni03B4]-granule secretion is extensively described together with a case report of a patient suffering from HPS type 1.

Schlüsselwörter

Bernard-Soulier Syndrom - Glanzmann Thrombasthenie - Hermansky-Pudlak Syndrom - thrombozytäre Rezeptoren - granuläre Sekretion 1

Keywords

Bernard-Soulier syndrome - Glanzmann thrombasthenia - Hermansky-Pudlak syndrome - platelet receptors - granule secretion

Full Text

References

References
1 Nurden A, Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function.. J Thromb Haemost 2011; 9 (Suppl. 01) 76-91.
2 Shiraga M, Miyata S, Kato H. et al. Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon.. J Thromb Haemost 2005; 3: 2315-2323.
3 Cattaneo M. The platelet P2Y(1)(2) receptor for adenosine diphosphate: congenital and drug-induced defects.. Blood 2011; 117: 2102-2112.
4 Lecchi A, Razzari C, Paoletta S. et al. Identification of a new dysfunctional platelet P2Y12 receptor variant, associated with bleeding diathesis.. Blood 2015; 125: 1006-1013.
5 Goto S, Tamura N, Handa S. et al. Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions.. Circulation 2002; 106: 266-272.
6 Arthur JF, Dunkley S, Andrews RK. Platelet glyco-protein VI-related clinical defects.. Br J Haematol 2007; 139: 363-372.
7 Gothwal M, Sandrock-Lang K, Zieger B. Genetics of inherited platelet disorders.. Hamostaseologie 2014; 34: 133-141.
8 Sandrock K, Zieger B. Current Strategies in Diagnosis of Inherited Storage Pool Defects.. Transfus Med Hemother 2010; 37: 248-258.
9 Bernard J, Soulier JP. Sem Hop 1948; 24: 3217-3223.
10 Inoue O, Suzuki-Inoue K, Ozaki Y. Redundant mechanism of platelet adhesion to laminin and collagen under flow: involvement of von Wille-brand factor and glycoprotein Ib-IX-V.. J Biol Chem 2008; 283: 16279-16282.
11 Simon D, Kunicki T, Nugent D. Platelet function defects.. Haemophilia 2008; 14: 1240-1249.
12 Pham A, Wang J. Bernard-Soulier syndrome: an inherited platelet disorder.. Arch Pathol Lab Med 2007; 131: 1834-1836.
13 Kunishima S, Kamiya T, Saito H. Genetic abnormalities of Bernard-Soulier syndrome.. Int J Hematol 2002; 76: 319-327.
14 Kunishima S, Saito H. Congenital macrothrombocytopenias.. Blood Rev 2006; 20: 111-121.
15 Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions.. Thromb Hae-most 2008; 99: 253-263.
16 Lanza F. Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy).. Orphanet J Rare Dis 2006; 1: 46.
17 Savoia A, Kunishima S, De RD. et al. Spectrum of the mutations in Bernard-Soulier syndrome.. Hum Mutat 2014; 35: 1033-1045.
18 Zieger B, Jenny A, Tsakiris DA. et al. A large Swiss family with Bernard-Soulier syndrome – Correlation phenotype and genotype.. Hamostaseologie 2009; 29: 161-167.
19 Sumitha E, Jayandharan GR, David S. et al. Molecular basis of Bernard-Soulier syndrome in 27 patients from India.. J Thromb Haemost 2011; 9: 1590-1598.
20 Sandrock K, Knofler R, Greinacher A. et al. Novel mutation in Bernard-Soulier syndrome.. Transfus Med Hemother 2010; 37: 278-284.
21 Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macro-glycopeptide region.. Structure/function implications. J Biol Chem 1992; 267: 10055-10061.
22 George JN, Caen JP, Nurden AT. Glanzmann’s thrombasthenia: the spectrum of clinical disease.. Blood 1990; 75: 1383-1395.
23 Patel D, Vaananen H, Jirouskova M. et al. Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy.. Blood 2003; 101: 929-936.
24 Nurden AT. Glanzmann thrombasthenia.. Orphanet J Rare Dis 2006; 1: 10.
25 Bray PF, Barsh G, Rosa JP. et al. Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa.. Proc Natl Acad Sci USA 1988; 85: 8683-8687.
26 Heidenreich R, Eisman R, Surrey S. et al. Organization of the gene for platelet glycoprotein IIb.. Biochemistry 1990; 29: 1232-1244.
27 Wilhide CC, Jin Y, Guo Q. et al. The human inte-grin beta3 gene is 63 kb and contains a 5’-UTR sequence regulating expression.. Blood 1997; 90: 3951-3961.
28 Bray PF, Rosa JP, Lingappa VR. et al. Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa.. Proc Natl Acad Sci USA 1986; 83: 1480-1484.
29 Rosenberg N, Yatuv R, Sobolev V. et al. Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in patients with Glanzmann thrombasthenia enable GPIIb/IIIa complex formation, but impair its transport from the endoplasmic reticulum to the Golgi apparatus.. Blood 2003; 101: 4808-4815.
30 O’Toole TE, Loftus JC, Plow EF. et al. Efficient surface expression of platelet GPIIb-IIIa requires both subunits.. Blood 1989; 74: 14-18.
31 Nair S, Li J, Mitchell WB. et al. Two new beta3 inte-grin mutations in Indian patients with Glanzmann thrombasthenia: localization of mutations affecting cysteine residues in integrin beta3.. Thromb Haemost 2002; 88: 503-509.
32 Jallu V, Dusseaux M, Panzer S. et al. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function.. Hum Mutat 2010; 31: 237-246.
33 Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies.. Blood 1959; 14: 162-169.
34 Cutler DF. Introduction: lysosome-related organelles.. Semin Cell Dev Biol 2002; 13: 261-262.
35 Dell’Angelica EC, Mullins C, Caplan S, Bonifacino JS. Lysosome-related organelles.. FASEB J 2000; 14: 1265-1278.
36 Summers CG, Knobloch WH, Witkop Jr CJ, King RA. Hermansky-Pudlak syndrome.. Ophthalmic findings. Ophthalmology 1988; 95: 545-554.
37 Berz F, Weiss M, Belohradsky BH. Albinism, thrombopathy, ceroid storage disease – Hermansky-Pudlak syndrome.. Overview and description with immunodeficiency. Klin Pädiatr 1996; 208: 83-87.
38 Witkop CJ, Krumwiede M, Sedano H, White JG. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome.. Am J Hematol 1987; 26: 305-311.
39 Gahl WA, Brantly M, Kaiser-Kupfer MI. et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome).. N Engl J Med 1998; 338: 1258-1264.
40 Hermos CR, Huizing M, Kaiser-Kupfer MI, Gahl WA. Hermansky-Pudlak syndrome type 1: gene organization, novel mutations, and clinical-molecular review of non-Puerto Rican cases.. Hum Mutat 2002; 20: 482.
41 Brantly M, Avila NA, Shotelersuk V. et al. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1.. Chest 2000; 117: 129-136.
42 Garay SM, Gardella JE, Fazzini EP, Goldring RM. Hermansky-Pudlak syndrome.. Pulmonary manifestations of a ceroid storage disorder. Am J Med 1979; 66: 737-747.
43 Harmon KR, Witkop CJ, White JG. et al. Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome.. J Lab Clin Med 1994; 123: 617-627.
44 Korswagen LA, Huizing M, Simsek S. et al. A novel mutation in a Turkish patient with HermanskyPudlak syndrome type 5.. Eur J Haematol 2008; 80: 356-360.
45 Schinella RA, Greco MA, Cobert BL. et al. Hermansky-Pudlak syndrome with granulomatous colitis.. Ann Intern Med 1980; 92: 20-23.
46 Mahadeo R, Markowitz J, Fisher S, Daum F. Hermansky-Pudlak syndrome with granulomatous colitis in children.. J Pediatr 1991; 118: 904-906.
47 Enders A, Zieger B, Schwarz K. et al. Lethal hemophagocytic lymphohistiocytosis in HermanskyPudlak syndrome type II.. Blood 2006; 108: 81-87.
48 Schallreuter KU, Frenk E, Wolfe LS, Witkop CJ, Wood JM. Hermansky-Pudlak syndrome in a Swiss population.. Dermatology 1993; 187: 248-256.
49 Witkop CJ, Nunez BM, Rao GH. et al. Albinism and Hermansky-Pudlak syndrome in Puerto Rico.. Bol Asoc Med P R 1990; 82: 333-339.
50 Li W, Rusiniak ME, Chintala S. et al. Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles.. Bioessays 2004; 26: 616-628.
51 Huizing M, Gahl WA. Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes.. Curr Mol Med 2002; 2: 451-467.
52 Sandrock K, Bartsch I, Rombach N. et al. Compound heterozygous mutations in 2 siblings with Hermansky-Pudlak syndrome type 1 (HPS1).. Klin Pädiatr 2010; 222: 168-174.
53 Oh J, Ho L, Ala-Mello S. et al. Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity.. Am J Hum Genet 1998; 62: 593-598.